443 research outputs found
Data record for the article: TriggerPoint Injection for Post-Mastectomy Pain: A Simple Intervention with High Rate of Long-Term Relief
No full textThis
data record provides details of the data supporting the claims of the related article:
“TriggerPoint Injection for
Post-Mastectomy Pain: A Simple Intervention with High Rate of Long-Term Relief”.
The
related study aimed to assess the rate of long-term resolution of post-mastectomy
pain syndrome (PMPS) after trigger point injections to relieve neuropathic
pain.
Type of data:
Participant characteristics; outcomes from the intervention
Subject of
data: Women presenting with clinical symptoms consistent with PMPS.
Sample size:
52 patients
Population
characteristics: Women (aged 31-92) who underwent partial mastectomy with
reduction mammoplasty or mastectomy with or without reconstruction.
Recruitment:
Patients from a breast surgery practice at the University of California San
Francisco Breast Care Center
Date of data
collection: August 2010 to April 2018
Geographic
location: United States of America
Trial
registration number: none
Data
access
De-identified participant
data showing
1.
study participant characteristics
2.
surgery interventions and
complications
3.
comparisons between sample
characteristics and primary outcome
are openly
available as part of this figshare metadata
record in the file ‘Khoury_PainInjectionPatients_NewCodedDatabase_Deidentified.xlsx’.
Corresponding author(s) for this study
Laura
J. Esserman ([email protected]).
Study approval
None</p
A New Perspective on DCIS Using MRI: Correlation of Tumor and Vessel Proliferation with MR Signal Enhancement
No full text
A New Perspective on DCIS Using MRI: Correlation of Tumor and Vessel Proliferation with MR Signal Enhancement
No full text
Optimizing hormone therapy for breast cancer: Translating gains to the early-stage setting
No full textFirst-line CDK4/6 inhibitor ribociclib plus letrozole improves survival in the metastatic setting, but lack of accrual of African American women is a shortcoming. Predicting benefit in the early-stage setting and diverse enrollment in trials need to be priorities.1
The Current Role of Endocrine Therapy in Locally Advanced Breast Cancer to Improve Breast Conservation Rates
No full text
- …
